Hepatitis Monthly

Published by: Kowsar

Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) and its Clinical Characteristics in Overweight and Obese Children in the South East of Iran, 2017

Kokab Namakin 1 , Mahya Hosseini 2 , * , Mahmoud Zardast 3 and Mahyar Mohammadifard 4
Authors Information
1 Cardiovascular Research Center, Birjand University of Medical Sciences, Birjand, Iran
2 Pediatric Department, Student Research Center, Birjand University of Medical Sciences, Birjand, Iran
3 Infectious Research Center, Birjand University of Medical Sciences, Birjand, Iran
4 Fellowship of Interventional Radiology, Birjand University of Medical Sciences, Birjand, Iran
Article information
  • Hepatitis Monthly: December 28, 2018, 18 (12); e83525
  • Published Online: December 16, 2018
  • Article Type: Research Article
  • Received: August 21, 2018
  • Revised: November 17, 2018
  • Accepted: December 1, 2018
  • DOI: 10.5812/hepatmon.83525

To Cite: Namakin K, Hosseini M, Zardast M, Mohammadifard M. Prevalence of Non-Alcoholic Fatty Liver Disease (NAFLD) and its Clinical Characteristics in Overweight and Obese Children in the South East of Iran, 2017, Hepat Mon. 2018 ; 18(12):e83525. doi: 10.5812/hepatmon.83525.

Abstract
Copyright © 2018, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Methods
3. Results
4. Discussion
Footnotes
References
  • 1. Azizi-Soleiman F, lMotlagh ME, Qorbani M, Heshmat R, Ardalan G, Mansourian M, et al. Dietary habits and health related behaviors in Iranian children and adolescents: The CASPIAN-IV study. Int J Pediatr. 2016;4(7):2087-97. doi: 10.22038/IJP.2016.6975.
  • 2. Jimenez-Rivera C, Hadjiyannakis S, Davila J, Hurteau J, Aglipay M, Barrowman N, et al. Prevalence and risk factors for non-alcoholic fatty liver in children and youth with obesity. BMC Pediatr. 2017;17(1):113. doi: 10.1186/s12887-017-0867-z. [PubMed: 28446162]. [PubMed Central: PMC5406891].
  • 3. Vajro P, Lenta S, Socha P, Dhawan A, McKiernan P, Baumann U, et al. Diagnosis of nonalcoholic fatty liver disease in children and adolescents: Position paper of the ESPGHAN Hepatology Committee. J Pediatr Gastroenterol Nutr. 2012;54(5):700-13. doi: 10.1097/MPG.0b013e318252a13f. [PubMed: 22395188].
  • 4. Chan DF, Li AM, Chu WC, Chan MH, Wong EM, Liu EK, et al. Hepatic steatosis in obese Chinese children. Int J Obes Relat Metab Disord. 2004;28(10):1257-63. doi: 10.1038/sj.ijo.0802734. [PubMed: 15278103].
  • 5. Lavine JE, Schwimmer JB. Nonalcoholic fatty liver disease in the pediatric population. Clin Liver Dis. 2004;8(3):549-58. viii-ix. doi: 10.1016/j.cld.2004.04.010. [PubMed: 15331063].
  • 6. Malespin M, Sleesman B, Lau A, Wong SS, Cotler SJ. Prevalence and correlates of suspected nonalcoholic fatty liver disease in Chinese American children. J Clin Gastroenterol. 2015;49(4):345-9. doi: 10.1097/MCG.0000000000000121. [PubMed: 24667593].
  • 7. Sartorio A, Del Col A, Agosti F, Mazzilli G, Bellentani S, Tiribelli C, et al. Predictors of non-alcoholic fatty liver disease in obese children. Eur J Clin Nutr. 2007;61(7):877-83. doi: 10.1038/sj.ejcn.1602588. [PubMed: 17151586].
  • 8. Mazzone L, Postorino V, De Peppo L, Della Corte C, Lofino G, Vassena L, et al. Paediatric non-alcoholic fatty liver disease: Impact on patients and mothers' quality of life. Hepat Mon. 2013;13(3). e7871. doi: 10.5812/hepatmon.7871. [PubMed: 23745129]. [PubMed Central: PMC3669678].
  • 9. Alavian SM, Mohammad-Alizadeh AH, Esna-Ashari F, Ardalan G, Hajarizadeh B. Non-alcoholic fatty liver disease prevalence among school-aged children and adolescents in Iran and its association with biochemical and anthropometric measures. Liver Int. 2009;29(2):159-63. doi: 10.1111/j.1478-3231.2008.01790.x. [PubMed: 18492015].
  • 10. Amirkalali B, Poustchi H, Keyvani H, Khansari MR, Ajdarkosh H, Maadi M, et al. Prevalence of non-alcoholic fatty liver disease and its predictors in north of Iran. Iran J Public Health. 2014;43(9):1275-83. [PubMed: 26175982]. [PubMed Central: PMC4500430].
  • 11. Moghaddasifar I, Lankarani KB, Moosazadeh M, Afshari M, Ghaemi A, Aliramezany M, et al. Prevalence of non-alcoholic fatty liver disease and its related factors in Iran. Int J Organ Transplant Med. 2016;7(3):149-60. [PubMed: 27721961]. [PubMed Central: PMC5054138].
  • 12. Taghavi Ardakani A, Sharif MR, Kheirkhah D. Fatty liver disease in obese children in Kashan, Iran. Caspian J Pediatr. 2015;1(1):17-21.
  • 13. Namakin K, Mohammadifard M, Zardast M, Ebrahimabadi N. The relationship between non-alcoholic fatty liver disease and metabolic syndrome in children. Int J Sch Health. 2017;4(1). e38135. doi: 10.17795/intjsh-38135.
  • 14. Alizadeh A, Mansour-Ghanaei F, Roozdar A, Joukar F, Sepehrimanesh M, Hojati SA, et al. Laboratory tests, liver vessels color doppler sonography, and fibroscan findings in patients with nonalcoholic fatty liver disease: An observation study. J Clin Imaging Sci. 2018;8:12. doi: 10.4103/jcis.JCIS_93_17. [PubMed: 29692949]. [PubMed Central: PMC5894278].
  • 15. Uchil D, Pipalia D, Chawla M, Patel R, Maniar S; Narayani, et al. Non-alcoholic fatty liver disease (NAFLD)--the hepatic component of metabolic syndrome. J Assoc Physicians India. 2009;57:201-4. [PubMed: 19588647].
  • 16. El-Koofy N, El-Karaksy H, El-Akel W, Helmy H, Anwar G, El-Sayed R, et al. Ultrasonography as a non-invasive tool for detection of nonalcoholic fatty liver disease in overweight/obese Egyptian children. Eur J Radiol. 2012;81(11):3120-3. doi: 10.1016/j.ejrad.2012.06.020. [PubMed: 22817846].
  • 17. Fattahi MR, Niknam R, Safarpour A, Sepehrimanesh M, Lotfi M. The prevalence of metabolic syndrome in non-alcoholic fatty liver disease: A population-based study. Middle East J Dig Dis. 2016;8(2):131-7. doi: 10.15171/mejdd.2016.18. [PubMed: 27252820]. [PubMed Central: PMC4885612].
  • 18. Kazemi SA, Kamali K, Asgari L, Eftekhari K. Assessment of the relationship between prevalence of reporting fatty liver disease by ultrasound and body mass index in children. Iran J Pediatr. 2017;27(1). doi: 10.5812/ijp.8028.
  • 19. Abangah G, Yousefi A, Asadollahi R, Veisani Y, Rahimifar P, Alizadeh S. Correlation of body mass index and serum parameters with ultrasonographic grade of fatty change in non-alcoholic fatty liver disease. Iran Red Crescent Med J. 2014;16(1). e12669. doi: 10.5812/ircmj.12669. [PubMed: 24719704]. [PubMed Central: PMC3964422].
  • 20. Adibi A, Kelishadi R, Beihaghi A, Salehi H, Talaei M. Sonographic fatty liver in overweight and obese children, a cross sectional study in Isfahan. Endokrynol Pol. 2009;60(1):14-9. [PubMed: 19224500].
  • 21. Di Sessa A, Umano GR, Miraglia del Giudice E. The association between non-alcoholic fatty liver disease and cardiovascular risk in children. Children (Basel). 2017;4(7). doi: 10.3390/children4070057. [PubMed: 28686220]. [PubMed Central: PMC5532549].
  • 22. Schwimmer JB, Middleton MS, Deutsch R, Lavine JE. A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis. Aliment Pharmacol Ther. 2005;21(7):871-9. doi: 10.1111/j.1365-2036.2005.02420.x. [PubMed: 15801922].
  • 23. Tominaga K, Fujimoto E, Suzuki K, Hayashi M, Ichikawa M, Inaba Y. Prevalence of non-alcoholic fatty liver disease in children and relationship to metabolic syndrome, insulin resistance, and waist circumference. Environ Health Prev Med. 2009;14(2):142-9. doi: 10.1007/s12199-008-0074-5. [PubMed: 19568858]. [PubMed Central: PMC2684773].
  • 24. Fu CC, Chen MC, Li YM, Liu TT, Wang LY. The risk factors for ultrasound-diagnosed non-alcoholic fatty liver disease among adolescents. Ann Acad Med Singapore. 2009;38(1):15-7. [PubMed: 19221666].
  • 25. Summart U, Thinkhamrop B, Chamadol N, Khuntikeo N, Songthamwat M, Kim CS. Gender differences in the prevalence of nonalcoholic fatty liver disease in the northeast of Thailand: A population-based cross-sectional study. F1000Res. 2017;6:1630. doi: 10.12688/f1000research.12417.2. [PubMed: 29093809]. [PubMed Central: PMC5645706].
  • 26. Florentino GS, Cotrim HP, Vilar CP, Florentino AV, Guimaraes GM, Barreto VS. Nonalcoholic fatty liver disease in menopausal women. Arq Gastroenterol. 2013;50(3):180-5. doi: 10.1590/S0004-28032013000200032. [PubMed: 24322188].
  • 27. Ryu S, Suh BS, Chang Y, Kwon MJ, Yun KE, Jung HS, et al. Menopausal stages and non-alcoholic fatty liver disease in middle-aged women. Eur J Obstet Gynecol Reprod Biol. 2015;190:65-70. doi: 10.1016/j.ejogrb.2015.04.017. [PubMed: 25988514].
  • 28. Ayonrinde OT, Olynyk JK, Beilin LJ, Mori TA, Pennell CE, de Klerk N, et al. Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease. Hepatology. 2011;53(3):800-9. doi: 10.1002/hep.24097. [PubMed: 21374659].
  • 29. Zardast M, Taheri F, Gholinejadan A, Namakin K, Javadinia S. The relationship between serum 25-hydroxyvitamin d levels and metabolic syndrome in Birjand children, east of Iran. Int J Pediatr. 2016;4(5):1759-66. doi: 10.22038/ijp.2016.6748.
  • 30. Foroughi M, Maghsoudi Z, Ghiasvand R, Iraj B, Askari G. Effect of vitamin D supplementation on C-reactive protein in patients with nonalcoholic fatty liver. Int J Prev Med. 2014;5(8):969-75. [PubMed: 25489444]. [PubMed Central: PMC4258669].
  • 31. Bydder GM, Chapman RWG, Harry D, Bassan L, Sherlock S, Kreel L. Computed tomography attenuation values in fatty liver. J Comput Tomography. 1981;5(1):33-5. [PubMed: 7273824].
  • 32. Di Martino M, Pacifico L, Bezzi M, Di Miscio R, Sacconi B, Chiesa C, et al. Comparison of magnetic resonance spectroscopy, proton density fat fraction and histological analysis in the quantification of liver steatosis in children and adolescents. World J Gastroenterol. 2016;22(39):8812-9. doi: 10.3748/wjg.v22.i39.8812. [PubMed: 27818597]. [PubMed Central: PMC5075556].
  • 33. Idilman IS, Keskin O, Celik A, Savas B, Elhan AH, Idilman R, et al. A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease. Acta Radiol. 2016;57(3):271-8. doi: 10.1177/0284185115580488. [PubMed: 25855666].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments